semaglutide news oct 26 2025 The FDA has approved the first GLP-1 pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular Semaglutide dose may matter more

After all, the origins of GLP-1 biology comes from examining insulin and glucagon pathways, and the first approved GLP-1 drug, Exenatide, was indicated for Type 2 Diabetes

These medications are typically administered once or twice daily and are largely eliminated from the system within 24 hours

Case Reports and Additional Evidence A case report published in Neuro-Ophthalmology described a 73-year-old man with type 2 diabetes, obesity, and hypertension who developed bilateral NAION after significant weight loss and postural hypotension while on semaglutide

A lack of protein in the diet can lead to weak, brittle hair or even hair loss